New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
13:13 EDTGALTGalectin Therapeutics volatility elevated into results from fatty liver disease
Galectin Therapeutics April call option implied volatility is at 194, May is at 143, July is at 112; compared to its 26-week average of 99 according to Track Data, suggesting large near term price movement into reporting results from the first cohort of its Phase 1 clinical trial examining GR-MD-02 in fatty liver disease.
News For GALT From The Last 14 Days
Check below for free stories on GALT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
08:07 EDTGALTGalectin Therapeutics issued U.S. patent for GR-MD-02
Subscribe for More Information
September 12, 2014
15:12 EDTGALTGalectin Therapeutics says in ongoing talks with large pharma companies
Subscribe for More Information
September 11, 2014
07:25 EDTGALTAegis to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use